Overview

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

Status:
Not yet recruiting
Trial end date:
2023-06-15
Target enrollment:
Participant gender:
Summary
Prospective, single center, non-randomized, pilot study to assess the feasibility of IA TNK following standard of care mechanical thrombectomy (MT) in patients with AIS. Participants will receive IA TNK after achieving mTICI 2b or 2c reperfusion with standard of care MT. Patients enrolled into the study will be followed for 3 months after treatment with IA TNK.
Phase:
Phase 2
Details
Lead Sponsor:
ProMedica Health System
Collaborator:
Genentech, Inc.
Treatments:
Tenecteplase